Schedule dependent effectiveness of CCNU and 5-fluorouracil in experimental chemotherapy.
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage* / Q000627:therapeutic use; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D008130:Lomustine / Q000008:administration & dosage* / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D051379:Mice; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000008:administration & dosage*; D012516:Osteosarcoma / Q000188:drug therapy
D009607:Nitrosourea Compounds; D008130:Lomustine; D005472:Fluorouracil